SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 143 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31 | -96.8% | 51,794 | -93.0% | 0.00% | -100.0% |
| Q2 2023 | $964 | +13.1% | 741,806 | +53.2% | 0.01% | -10.0% |
| Q1 2023 | $852 | -99.8% | 484,151 | +302.4% | 0.01% | +100.0% |
| Q2 2022 | $498,000 | -12.8% | 120,316 | +57.8% | 0.01% | +66.7% |
| Q4 2021 | $571,000 | +65.5% | 76,247 | +98.6% | 0.00% | +50.0% |
| Q3 2021 | $345,000 | -65.6% | 38,393 | -54.2% | 0.00% | -77.8% |
| Q2 2021 | $1,002,000 | +237.4% | 83,755 | +339.5% | 0.01% | +50.0% |
| Q4 2020 | $297,000 | +206.2% | 19,058 | +84.5% | 0.01% | +100.0% |
| Q3 2020 | $97,000 | -47.3% | 10,329 | -49.2% | 0.00% | -66.7% |
| Q3 2019 | $184,000 | +46.0% | 20,351 | +78.5% | 0.01% | -84.7% |
| Q2 2015 | $126,000 | – | 11,400 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
| Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
| Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
| WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
| Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
| EMC Capital Management | 48,992 | $765,000 | 0.58% |
| Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
| Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
| Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |